BioClin Therapeutics, Inc. Company Profile

15:41 EST 22nd January 2019 | BioPortfolio

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in the treatment of metastatic bladder cancer. The first clinical study is a Phase 1b/2 study of B-701 in combination with docetaxel. The study includes cohorts in which patients with FGFR3 mutation or fusion will be enrolled; patients will be administered B-701 plus docetaxel, or B-701 alone as monotherapy. The second study is evaluating the combination of B-701 and atezolizumab in mUC patients and will include those with overexpressed FGFR3 as well as those with FGFR3 mutation or fusion in their tumors. B-701 is also being tested in an on-going investigator sponsored study evaluating the combination of B-701 and pembrolizumab in mUC patients.

News Articles [654 Associated News Articles listed on BioPortfolio]

BioClin Chairman Scott Myers Adds CEO Role

Scott Myers, chairman of BioClin Therapeutics, has been appointed CEO of the San Leandro, CA, company. Myers has been chairman of BioClin since June. The company says Myers will continue in his role a...

BioClin Therapeutics to Participate in BTIG Biotech Conference

BioClin Therapeutics, Inc., a privately-held clinical stage drug development company, today announced its participation in the BTIG Biotech Conference taking place at the Langham ...

BioClin Therapeutics Announces New Leadership to Advance Late-Stage Bladder Cancer Development Program

BioClin Therapeutics, Inc., a privately-held clinical stage drug development company, today announced the appointment of Scott Myers as Chief Executive Officer, and Julie Eastland...

Almac Group Details Analytical Services

Following the successful acquisition of BioClin Research Laboratories in 2017, Almac’s Sciences Business Unit has expanded

BioClin Therapeutics Announces Name Change to Rainier Therapeutics

BioClin Therapeutics, Inc., a privately-held clinical stage drug development company focused on helping patients in the high unmet need of bladder cancer, today announced the comp...

Almac forms analytical group, increases capacity

Almacâs Sciences Business Unit has combined its capabilities with BioClin to form an analytical group spanning the UK, Europe, and North America.

Atomo Diagnostics Wins Approval For Australia’s First HIV Self-Test, And Secures WHO Endorsement

Atomo Diagnostics’ HIV Self Test has got the green light as Australia’s first HIV self-test and won approval from the...   

Harpoon Therapeutics Appoints Ms. Julie Eastland, Biotech Industry Veteran, to Board of Directors

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company developing a novel class of T cell engaging therapeutics, announced today that it has appointed Ms. Julie Eastla...

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [Kastle Therapeutics, LLC]


Olopatadine hydrochloride [Somerset Therapeutics, LLC]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [Breathe Easy Therapeutics, Inc]


Diclofenac sodium delayed release [Cambridge Therapeutics Technologies, LLC]

Diclofenac Sodium

Olopatadine hydrochloride [A-S Medication Solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [469 Associated PubMed Articles listed on BioPortfolio]

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro.

In recent times, co-delivery of therapeutics has emerged as a promising strategy for treating dreadful diseases such as cancer.

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Clinical Trials [169 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1295 Associated Companies listed on BioPortfolio]

BioClin Research Laboratories Ltd.,

BioClin is Irelands leading GLP certified, FDA and cGMP compliant contract research laboratory.BioClin maintains this position due to its versatility and capacity to integrate its exceptional technica...

BioClin Health Research, Inc.

BioClin Health Research, Inc. became incorporated in August of 2000, opening its first office in Richmond, British Columbia, Canada. BioClin is wholly owned by its founders Sandra and Jonathan Beard....

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "BioClin Therapeutics, Inc." on BioPortfolio

We have published hundreds of BioClin Therapeutics, Inc. news stories on BioPortfolio along with dozens of BioClin Therapeutics, Inc. Clinical Trials and PubMed Articles about BioClin Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioClin Therapeutics, Inc. Companies in our database. You can also find out about relevant BioClin Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Corporate Database Quicklinks

Searches Linking to this Company Record